« Previous
Next »
Titles
- Necessary automated external defibrillator accessories: policy regarding compliance date : guidance for industry, stakeholders, health care professionals, and Food and Drug Administration staff1
- Nonallergic rhinitis: developing drug products for treatment1
- Notifying FDA of a permanent discontinuance or interruption in manufacturing under section 506C of the FD&C Act1
- Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry1